International Current Affairs

Latest International Current Affairs 2019 with news summaries and current events in International developments, geopolitical, organizations, groupings and fora related updates for India and world with all important national news updates and events for the year 2019.

India to attend NAM Summit

On May 4, 2020, PM Modi will attend the NAM Summit representing India through a video conference. The Summit is to discuss COVID-19 challenges and solutions.


This is the first NAM Summit being attended by the Mr Modi since he was sworn in as the Prime Minister in 2014. Mr Modi both the summits as PM in 2016 and 2019. The 2016 summit was held in Venezuels and 2019 in Azerbaijan.

In 2012, the former PM Manmohan Singh participated at the Tehran NAM summit.

NAM Summits

The NAM is Non-Aligned Movement forum of 120 developing countries. After the United Nations, NAM is the largest grouping of states. The summit was agreed to convene at the Bandung Conference in 1955.

NAM was established in 1961 through initiatives of Indian PM Jawaharlal Nehru, Yugoslav President Josip Broz Tito and Egyptian President Gamal Abdel Nasser.

The main aim of the summit is to build aspiration towards collective security, terminating dominance of one country over other and expansion of freedom. The NAM also aimed to soften the cold war that was building among the developed nations.

Principles of NAM

The five major principles of NAM include mutual respect, mutual non-aggression, equality and mutual benefit, mutual non-interference in domestic affairs and peaceful coexistence.

USFDA approves emergency use of an investigational vaccine, Remdesivir

The United States Food and Drug Regulatory body recently allowed emergency use of anti-viral investigational vaccine Remdesivir to treat COVID-19 patients.


The USFDA has approved the vaccine after an Indian-American physician, Aruna Subramaninan’s report on Remdesivir. According to the report, the vaccine shortened the recovery times of people that have fallen ill due to COVID-19 virus. The FDA has provided emergency use authorization of the drug.


Remdesivir was developed to treat Ebola virus and Marburg virus. However, it was found to be ineffective in treating these diseases.

International Nonproprietary Name

Remdesivir is an International Nonproprietary Name (INN). The INN is provided to a pharmaceutical drug or active ingredient. The INN is issued in Latin, English, Russian, French, Spanish, Chinese and Arabic.

Emergency Use Authorization

The Emergency Use Authorization in the United States to approve drugs during emergency. Earlier, the US FDA had approved use of diagnostic and therapeutic tools to identify and respond 2009 swine flu outbreak.

In 2013, the FDA issued Emergency Authorization Use of CDC Human Influenza virus.

Remdesivir trial by WHO

WHO had launched 4 mega trials to treat COVID-19. It includes Remdesivir, HCQ (Hydroxychloroquine), combination of Lopinavir and Ritonavir and Interferon-beta along with the combination of Lopinavir and Ritonavir.